Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01373450
What this trial is testing

Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 12
Testing effectiveness (Phase 2)Study completedNCT03017352
What this trial is testing

Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases

Who this might be right for
Diabetes Mellitus, Type 1
Filip Krag Knop 108
Testing effectiveness (Phase 2)Looking for participantsNCT05356104
What this trial is testing

GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)

Who this might be right for
Cerebral Small Vessel Disease
Chinese University of Hong Kong 110
Very early researchTemporarily pausedNCT06171152
What this trial is testing

Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues

Who this might be right for
Multiple SclerosisLong COVIDLong Covid19+4 more
University of Chicago 30
Not applicableStudy completedNCT06003985
What this trial is testing

Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists

Who this might be right for
Gastric UltrasoundGlucagon-like Peptide 1Point of Care Ultrasound
Hospital for Special Surgery, New York 354
Testing effectiveness (Phase 2)Active Not RecruitingNCT07073417
What this trial is testing

Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)

Who this might be right for
ObesityWeight Management
Hangzhou Sciwind Biosciences Co., Ltd. 163
Not applicableLooking for participantsNCT07210684
What this trial is testing

Effects of Dihydroberberine (DHB) on GLP-1, Glycemic Control, Appetite, and Mood in Adults With Pre-Diabetes

Who this might be right for
Prediabetes
Nanjing Nutrabuilding Bio-tech Co., Ltd. 54
Testing effectiveness (Phase 2)Study completedNCT01001104
What this trial is testing

LY2189265 in Japanese Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 145
Not applicableLooking for participantsNCT06666049
What this trial is testing

Gastric POCUS for Airway Management in Patients Using Glucagon-like Peptide-1 Receptor Agonist (Multicentric)

Who this might be right for
Aspiration Pneumonia
Clinica Universidad de Navarra, Universidad de Navarra 39
Early research (Phase 1)Study completedNCT07294898
What this trial is testing

Investigate the Effect of a Low-fat Meal and Evening Dosing on KAI-7535 in Participants Living With Obesity or Overweight

Who this might be right for
ObesityOverweight
Kailera 18
Large-scale testing (Phase 3)Looking for participantsNCT07284511
What this trial is testing

A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar

Who this might be right for
Type 1 DiabetesType 1 Diabetes MellitusT1D+2 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 105
Large-scale testing (Phase 3)Looking for participantsNCT07775404
What this trial is testing

Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus

Who this might be right for
ObesityOverweight
AstraZeneca 351
Not applicableStudy completedNCT07566299
What this trial is testing

Early GLP-1 Receptor Agonist and SGLT2 Inhibitor Add-On Strategies in Adults With Obesity, Type 2 Diabetes, Cardiovascular-Kidney-Metabolic Syndrome Stage 2-3, and Metabolic Dysfunction-Associated Steatotic Liver Disease

Who this might be right for
Obesity Type 2 Diabetes MellitusCardiovascular-kidney-metabolic SyndromeMetabolic Dysfunction-Associated Steatotic Liver Disease
Chung Shan Medical University 118,805
Large-scale testing (Phase 3)Looking for participantsNCT07165028
What this trial is testing

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company 4,500
Post-approval studies (Phase 4)Looking for participantsNCT06774079
What this trial is testing

Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients

Who this might be right for
Crohn Disease
University of Miami 24
Testing effectiveness (Phase 2)Study completedNCT02771574
What this trial is testing

Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric Hypoglycemia

Who this might be right for
Post Bariatric Hypoglycemia
Tracey McLaughlin 19
Post-approval studies (Phase 4)Study completedNCT04307797
What this trial is testing

Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants with Type 2 Diabetes

Who this might be right for
Type 2 DiabetesObesity
Cambridge University Hospitals NHS Foundation Trust 10
Not applicableStudy completedNCT00939679
What this trial is testing

Effect of Gastric Bypass Surgery on Energy Metabolism

Who this might be right for
Obesity
University of Copenhagen 32
Not applicableLooking for participantsNCT07387796
What this trial is testing

Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation

Who this might be right for
Drug DiscontinuationSubstance Use DisordersEating Behavior Changes+1 more
The University of Texas at Dallas 40
Not applicableUnknownNCT05446415
What this trial is testing

L-Cell Activity in Small Intestine as Biliopancreatic Loop in Obese Patients With DM2 Submitted to RYGBP

Who this might be right for
Severe ObesityType 2 Diabetes Mellitus in Obese
University of Sao Paulo General Hospital 20
Next Page